Published in Br J Haematol on July 01, 1997
The junctional adhesion molecule 3 (JAM-3) on human platelets is a counterreceptor for the leukocyte integrin Mac-1. J Exp Med (2002) 2.42
Pleiotropic effects of intravascular haemolysis on vascular homeostasis. Br J Haematol (2009) 1.20
β-thalassemia intermedia: a clinical perspective. Cold Spring Harb Perspect Med (2012) 1.14
Prothrombin activation in blood coagulation: the erythrocyte contribution to thrombin generation. Blood (2012) 1.08
Splenectomy: a strong risk factor for pulmonary hypertension in patients with thalassaemia. Heart (2006) 1.00
Generation of megakaryocytic progenitors from human embryonic stem cells in a feeder- and serum-free medium. PLoS One (2013) 0.90
Future alternative therapies for β-thalassemia. Expert Rev Hematol (2009) 0.89
Analysis of adenoviral attachment to human platelets. Virol J (2009) 0.84
Thalassemia and venous thromboembolism. Mediterr J Hematol Infect Dis (2011) 0.83
Benefits of chronic blood transfusion in hemoglobin E/β thalassemia with pulmonary arterial hypertension. Int J Gen Med (2014) 0.80
Elevated tricuspid regurgitant jet velocity in subgroups of thalassemia patients: insight into pathophysiology and the effect of splenectomy. Ann Hematol (2014) 0.79
Coagulopathy in Beta-thalassemia: current understanding and future perspectives. Mediterr J Hematol Infect Dis (2009) 0.79
Differential regulation of the apoptotic machinery during megakaryocyte differentiation and platelet production by inhibitor of apoptosis protein Livin. Cell Death Dis (2013) 0.77
Treatment of β-Thalassemia/Hemoglobin E with Antioxidant Cocktails Results in Decreased Oxidative Stress, Increased Hemoglobin Concentration, and Improvement of the Hypercoagulable State. Oxid Med Cell Longev (2015) 0.75
Intravascular haemolysis with haemoglobinuria in a splenectomized patient with severe Plasmodium knowlesi malaria. Malar J (2016) 0.75
Hypercoagulability in congenital haemolytic anaemias. Blood Transfus (2012) 0.75
Fish-Free Diet in Patients with Phenylketonuria Is Not Associated with Early Atherosclerotic Changes and Enhanced Platelet Activation. PLoS One (2015) 0.75
Pulmonary hypertension associated with thalassemia syndromes. Ann N Y Acad Sci (2016) 0.75
A comparison of enoxaparin with placebo for the prevention of venous thromboembolism in acutely ill medical patients. Prophylaxis in Medical Patients with Enoxaparin Study Group. N Engl J Med (1999) 6.88
Structural mechanism for rifampicin inhibition of bacterial rna polymerase. Cell (2001) 6.10
The RNA-DNA hybrid maintains the register of transcription by preventing backtracking of RNA polymerase. Cell (1997) 4.10
A structural model of transcription elongation. Science (2000) 4.09
Photoradiation therapy for the treatment of malignant tumors. Cancer Res (1978) 4.01
Unstable beta-globin mRNA in mRNA-deficient beta o thalassemia. Cell (1981) 3.80
Transcript cleavage factors from E. coli. Cell (1993) 3.78
Cause of portal or hepatic venous thrombosis in adults: the role of multiple concurrent factors. Hepatology (2000) 3.16
Increased frequency of genetic thrombophilia in women with complications of pregnancy. N Engl J Med (1999) 3.13
A unique natural human IgG antibody with anti-alpha-galactosyl specificity. J Exp Med (1984) 3.07
Rifampicin region revisited. New rifampicin-resistant and streptolydigin-resistant mutants in the beta subunit of Escherichia coli RNA polymerase. J Biol Chem (1993) 3.07
Discontinuous mechanism of transcription elongation. Science (1994) 2.91
The analysis of 51 genes in DSM-IV combined type attention deficit hyperactivity disorder: association signals in DRD4, DAT1 and 16 other genes. Mol Psychiatry (2006) 2.80
Current outcome of portal vein thrombosis in adults: risk and benefit of anticoagulant therapy. Gastroenterology (2001) 2.75
Reliability of psychiatrists' ratings in community case finding. Am J Public Health Nations Health (1967) 2.64
Transcription processivity: protein-DNA interactions holding together the elongation complex. Science (1996) 2.58
Transport of anti-glycoprotein IIb/IIIa-antibodies into the alpha-granules of unstimulated human blood platelets. Thromb Haemost (1992) 2.58
Intrinsic transcript cleavage activity of RNA polymerase. Proc Natl Acad Sci U S A (1995) 2.45
EDTA-dependent pseudothrombocytopenia: a clinical study of 18 patients and a review of the literature. Am J Hematol (1991) 2.35
Non-specific serum iron in thalassaemia: an abnormal serum iron fraction of potential toxicity. Br J Haematol (1978) 2.07
The present status of the heterogeneity of fetal hemoglobin in beta-thalassemia: an attempt to unify some observations in thalassemia and related conditions. Ann N Y Acad Sci (1974) 1.99
Thromboembolism in patients with the 'lupus'-type circulating anticoagulant. Arch Intern Med (1984) 1.92
Mapping of catalytic residues in the RNA polymerase active center. Science (1996) 1.91
Recombinant Escherichia coli RNA polymerase: purification of individually overexpressed subunits and in vitro assembly. Protein Expr Purif (1993) 1.89
Location, structure, and function of the target of a transcriptional activator protein. Genes Dev (1994) 1.88
Coupling between transcription termination and RNA polymerase inchworming. Cell (1995) 1.86
GreA protein: a transcription elongation factor from Escherichia coli. Proc Natl Acad Sci U S A (1992) 1.85
Rapid RNA polymerase genetics: one-day, no-column preparation of reconstituted recombinant Escherichia coli RNA polymerase. Proc Natl Acad Sci U S A (1995) 1.85
Expression of heparanase by platelets and circulating cells of the immune system: possible involvement in diapedesis and extravasation. Invasion Metastasis (1992) 1.79
Crystal structure of the GreA transcript cleavage factor from Escherichia coli. Nature (1995) 1.79
Proliferation and maturation of human erythroid progenitors in liquid culture. Blood (1989) 1.78
Reliability of newly trained raters in community case finding. Am J Public Health Nations Health (1967) 1.71
The prothrombin 20209 C-->T mutation in Jewish-Moroccan Caucasians: molecular analysis of gain-of-function of 3' end processing. J Thromb Haemost (2006) 1.67
Laparoscopic accessory splenectomy for recurrent idiopathic thrombocytopenic purpura and hemolytic anemia. Surg Endosc (2000) 1.61
Comparison of cardiac catheterization and Doppler echocardiography in the decision to operate in aortic and mitral valve disease. J Am Coll Cardiol (1991) 1.57
The effects of protein conformation on the heme symmetry in high spin ferric heme proteins as studied by electron paramagnetic resonance. J Biol Chem (1971) 1.57
Adding fresh frozen plasma to rituximab for the treatment of patients with refractory advanced CLL. QJM (2008) 1.56
Heparanase activity expressed by platelets, neutrophils, and lymphoma cells releases active fibroblast growth factor from extracellular matrix. Cell Regul (1990) 1.55
Plasma chitotriosidase activity in patients with beta-thalassemia. Am J Hematol (2002) 1.55
Histidine-tagged RNA polymerase of Escherichia coli and transcription in solid phase. Methods Enzymol (1996) 1.53
Protein-RNA interactions in the active center of transcription elongation complex. Proc Natl Acad Sci U S A (1996) 1.52
RifR mutations in the beginning of the Escherichia coli rpoB gene. Mol Gen Genet (1994) 1.52
Two modes of transcription initiation in vitro at the rrnB P1 promoter of Escherichia coli. J Biol Chem (1993) 1.51
Brief report: tumor lysis syndrome following treatment with 2-chlorodeoxyadenosine for refractory chronic lymphocytic leukemia. N Engl J Med (1993) 1.51
Photoradiation in the treatment of recurrent breast carcinoma. J Natl Cancer Inst (1979) 1.50
Histidine-tagged RNA polymerase: dissection of the transcription cycle using immobilized enzyme. Gene (1993) 1.49
Clinical and therapeutic experience in 712 Israeli patients with idiopathic thrombocytopenic purpura. Israeli ITP Study Group. Acta Haematol (1994) 1.48
Cancer incidence and mortality among beta-naphthylamine and benzidine dye workers in Moscow. Int J Epidemiol (1995) 1.47
Ovarian tissue banking in patients with Hodgkin's disease: is it safe? Fertil Steril (1998) 1.46
lac repressor acts by modifying the initial transcribing complex so that it cannot leave the promoter. Cell (1991) 1.44
Low molecular weight heparin for Hickman catheter--induced thrombosis in thrombocytopenic patients undergoing bone marrow transplantation. Cancer (1992) 1.42
Demonstration of a natural antigalactosyl IgG antibody on thalassemic red blood cells. Blood (1983) 1.41
Mapping of the priming substrate contacts in the active center of Escherichia coli RNA polymerase. J Biol Chem (1991) 1.41
Activated oxygen and haemolysis. Br J Haematol (1975) 1.41
Studies on the stability of oxyhemoglobin A and its constituent chains and their derivatives. J Biol Chem (1971) 1.38
Streptolydigin-resistant mutants in an evolutionarily conserved region of the beta' subunit of Escherichia coli RNA polymerase. J Biol Chem (1995) 1.38
Genetic evidence for multiple functions of the matrix protein of vesicular stomatitis virus. J Gen Virol (1990) 1.36
Recombinant RNA polymerase: inducible overexpression, purification and assembly of Escherichia coli rpo gene products. Gene (1990) 1.36
Structural roles of acetylcholinesterase variants in biology and pathology. Eur J Biochem (1999) 1.35
The beta subunit Rif-cluster I is only angstroms away from the active center of Escherichia coli RNA polymerase. J Biol Chem (1995) 1.35
Effects of irradiation on the release of growth factors from cultured bovine, porcine, and human endothelial cells. Cancer Res (1989) 1.33
The CXCR4 antagonist AMD3100 impairs survival of human AML cells and induces their differentiation. Leukemia (2008) 1.33
Mechanistic model of the elongation complex of Escherichia coli RNA polymerase. Cold Spring Harb Symp Quant Biol (1998) 1.28
Inhibition of heparanase-mediated degradation of extracellular matrix heparan sulfate by non-anticoagulant heparin species. Blood (1987) 1.26
Cardiopulmonary assessment in beta-thalassemia major. Chest (1990) 1.26
Blocking of the initiation-to-elongation transition by a transdominant RNA polymerase mutation. Science (1990) 1.24
Oxidative denaturation of red blood cells in thalassemia. Semin Hematol (1990) 1.24
Thrombin immobilized to extracellular matrix is a potent mitogen for vascular smooth muscle cells: nonenzymatic mode of action. Cell Regul (1990) 1.22
Leiomyosarcoma of the inferior vena cava propagating into the right atrium. Br Heart J (1968) 1.22
Modular organization of the catalytic center of RNA polymerase. Proc Natl Acad Sci U S A (1997) 1.22
Subcutaneous enoxaparin once or twice daily compared with intravenous unfractionated heparin for treatment of venous thromboembolic disease. Ann Intern Med (2001) 1.21
A non-essential domain of Escherichia coli RNA polymerase required for the action of the termination factor Alc. J Biol Chem (1994) 1.20
Spatial organization of transcription elongation complex in Escherichia coli. Science (1998) 1.20
Structural modules of the large subunits of RNA polymerase. Introducing archaebacterial and chloroplast split sites in the beta and beta' subunits of Escherichia coli RNA polymerase. J Biol Chem (1996) 1.20
Avian hemangioma retrovirus induces cell proliferation via the envelope (env) gene. Virology (2000) 1.19
Mapping of a contact for the RNA 3' terminus in the largest subunit of RNA polymerase. J Biol Chem (1991) 1.19
A high-density SNP linkage scan with 142 combined subtype ADHD sib pairs identifies linkage regions on chromosomes 9 and 16. Mol Psychiatry (2008) 1.18
Lipid membrane peroxidation in beta-thalassemia major. Blood (1976) 1.18
Denaturation of the normal and abnormal hemoglobin molecule. Semin Hematol (1974) 1.17
Factor V Leiden related Budd-Chiari syndrome. Gut (2001) 1.17
Diversity of beta-globin mutations in Israeli ethnic groups reflects recent historic events. Am J Hum Genet (1994) 1.16
The sigma subunit conserved region 3 is part of "5'-face" of active center of Escherichia coli RNA polymerase. J Biol Chem (1994) 1.16
Prediction of haemorrhagic diathesis in thrombocytopenia by mean platelet volume. Br Med J (Clin Res Ed) (1982) 1.13
[Analysis of a thermolabile mutant of vesicular stomatitis virus (VSV)]. Ann Inst Pasteur (Paris) (1971) 1.12
Role of haemichromes in the formation of inclusion bodies in haemoglobin H disease. Nature (1969) 1.12
Topology of the RNA polymerase active center probed by chimeric rifampicin-nucleotide compounds. Proc Natl Acad Sci U S A (1994) 1.12
Recovery of prostacyclin production by de-endothelialized rabbit aorta. Critical role of neointimal smooth muscle cells. J Clin Invest (1981) 1.11
Pathologic features of the placenta in women with severe pregnancy complications and thrombophilia. Obstet Gynecol (2001) 1.10
Escherichia coli RNA polymerase holoenzyme: rapid reconstitution from recombinant alpha, beta, beta', and sigma subunits. Methods Enzymol (1996) 1.09
A beta subunit mutation disrupting the catalytic function of Escherichia coli RNA polymerase. Proc Natl Acad Sci U S A (1991) 1.09
Acute promyelocytic leukaemia with t(15;17) following treatment of Hodgkin's disease--a report of 4 cases. Ann Oncol (1995) 1.09
Dominant lethal mutations near the 5' substrate binding site affect RNA polymerase propagation. J Biol Chem (1993) 1.08
Microsatellite instability and p53 mutations in therapy-related leukemia suggest mutator phenotype. Blood (1996) 1.08
Classification of anti-endothelial cell antibodies into antibodies against microvascular and macrovascular endothelial cells: the pathogenic and diagnostic implications. Arthritis Rheum (2001) 1.08
Active center rearrangement in RNA polymerase initiation complex. J Biol Chem (1993) 1.07
The catalytic mechanism of the manganese-containing superoxide dismutase of Escherichia coli studied by pulse radiolysis. J Am Chem Soc (1974) 1.07
High incidence of relapses in thrombotic thrombocytopenic purpura. Clinical study of 38 patients. Am J Med (1987) 1.07
beta 0-Thalassemia complicated by autoimmune hemolytic anemia. Globin synthesis during immunosuppressive therapy. Acta Haematol (1980) 1.06